世界の非GLP急性毒性市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non-GLP Acute Toxicology Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4162 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、非GLP急性毒性のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性毒性試験、in vitro細胞毒性試験、遺伝毒性試験）、用途別市場規模（げっ歯類、犬、ウサギ、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・非GLP急性毒性の市場動向 ・企業の競争状況、市場シェア ・非GLP急性毒性の種類別市場規模（急性毒性試験、in vitro細胞毒性試験、遺伝毒性試験） ・非GLP急性毒性の用途別市場規模（げっ歯類、犬、ウサギ、その他） ・非GLP急性毒性の北米市場規模2016-2027（アメリカ、カナダ） ・非GLP急性毒性のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・非GLP急性毒性のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非GLP急性毒性の中南米市場規模2016-2027（メキシコ、ブラジル） ・非GLP急性毒性の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（HSRL、Charles River、IITRI、CARE Research、MediTox sro、VivoPharm、Celerion、Bienta） ・結論

Non-GLP studies do not require all of the rigor of GLP studies. Although GLP is written into the Official Register of the United States, compliance with GLP is not required for in vitro drug metabolism and drug interaction studies. 

Market Analysis and Insights: Global Non-GLP Acute Toxicology Market
The global Non-GLP Acute Toxicology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-GLP Acute Toxicology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-GLP Acute Toxicology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-GLP Acute Toxicology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-GLP Acute Toxicology market.

Global Non-GLP Acute Toxicology Scope and Market Size
Non-GLP Acute Toxicology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-GLP Acute Toxicology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acute Toxicity Testing
In vitro Cytotoxicity Testing
Genotoxicity Testing

Segment by Application
Rodents
Canine
Rabbit
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
HSRL
Charles River
IITRI
CARE Research
MediTox sro
VivoPharm
Celerion
Bienta

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-GLP Acute Toxicology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute Toxicity Testing
1.2.3 In vitro Cytotoxicity Testing
1.2.4 Genotoxicity Testing
1.3 Market by Application
1.3.1 Global Non-GLP Acute Toxicology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rodents
1.3.3 Canine
1.3.4 Rabbit
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-GLP Acute Toxicology Market Perspective (2016-2027)
2.2 Non-GLP Acute Toxicology Growth Trends by Regions
2.2.1 Non-GLP Acute Toxicology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-GLP Acute Toxicology Historic Market Share by Regions (2016-2021)
2.2.3 Non-GLP Acute Toxicology Forecasted Market Size by Regions (2022-2027)
2.3 Non-GLP Acute Toxicology Industry Dynamic
2.3.1 Non-GLP Acute Toxicology Market Trends
2.3.2 Non-GLP Acute Toxicology Market Drivers
2.3.3 Non-GLP Acute Toxicology Market Challenges
2.3.4 Non-GLP Acute Toxicology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-GLP Acute Toxicology Players by Revenue
3.1.1 Global Top Non-GLP Acute Toxicology Players by Revenue (2016-2021)
3.1.2 Global Non-GLP Acute Toxicology Revenue Market Share by Players (2016-2021)
3.2 Global Non-GLP Acute Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-GLP Acute Toxicology Revenue
3.4 Global Non-GLP Acute Toxicology Market Concentration Ratio
3.4.1 Global Non-GLP Acute Toxicology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-GLP Acute Toxicology Revenue in 2020
3.5 Non-GLP Acute Toxicology Key Players Head office and Area Served
3.6 Key Players Non-GLP Acute Toxicology Product Solution and Service
3.7 Date of Enter into Non-GLP Acute Toxicology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-GLP Acute Toxicology Breakdown Data by Type
4.1 Global Non-GLP Acute Toxicology Historic Market Size by Type (2016-2021)
4.2 Global Non-GLP Acute Toxicology Forecasted Market Size by Type (2022-2027)

5 Non-GLP Acute Toxicology Breakdown Data by Application
5.1 Global Non-GLP Acute Toxicology Historic Market Size by Application (2016-2021)
5.2 Global Non-GLP Acute Toxicology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-GLP Acute Toxicology Market Size (2016-2027)
6.2 North America Non-GLP Acute Toxicology Market Size by Type
6.2.1 North America Non-GLP Acute Toxicology Market Size by Type (2016-2021)
6.2.2 North America Non-GLP Acute Toxicology Market Size by Type (2022-2027)
6.2.3 North America Non-GLP Acute Toxicology Market Size by Type (2016-2027)
6.3 North America Non-GLP Acute Toxicology Market Size by Application
6.3.1 North America Non-GLP Acute Toxicology Market Size by Application (2016-2021)
6.3.2 North America Non-GLP Acute Toxicology Market Size by Application (2022-2027)
6.3.3 North America Non-GLP Acute Toxicology Market Size by Application (2016-2027)
6.4 North America Non-GLP Acute Toxicology Market Size by Country
6.4.1 North America Non-GLP Acute Toxicology Market Size by Country (2016-2021)
6.4.2 North America Non-GLP Acute Toxicology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Non-GLP Acute Toxicology Market Size (2016-2027)
7.2 Europe Non-GLP Acute Toxicology Market Size by Type
7.2.1 Europe Non-GLP Acute Toxicology Market Size by Type (2016-2021)
7.2.2 Europe Non-GLP Acute Toxicology Market Size by Type (2022-2027)
7.2.3 Europe Non-GLP Acute Toxicology Market Size by Type (2016-2027)
7.3 Europe Non-GLP Acute Toxicology Market Size by Application
7.3.1 Europe Non-GLP Acute Toxicology Market Size by Application (2016-2021)
7.3.2 Europe Non-GLP Acute Toxicology Market Size by Application (2022-2027)
7.3.3 Europe Non-GLP Acute Toxicology Market Size by Application (2016-2027)
7.4 Europe Non-GLP Acute Toxicology Market Size by Country
7.4.1 Europe Non-GLP Acute Toxicology Market Size by Country (2016-2021)
7.4.2 Europe Non-GLP Acute Toxicology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-GLP Acute Toxicology Market Size (2016-2027)
8.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type
8.2.1 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application
8.3.1 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-GLP Acute Toxicology Market Size by Region
8.4.1 Asia-Pacific Non-GLP Acute Toxicology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-GLP Acute Toxicology Market Size (2016-2027)
9.2 Latin America Non-GLP Acute Toxicology Market Size by Type
9.2.1 Latin America Non-GLP Acute Toxicology Market Size by Type (2016-2021)
9.2.2 Latin America Non-GLP Acute Toxicology Market Size by Type (2022-2027)
9.2.3 Latin America Non-GLP Acute Toxicology Market Size by Type (2016-2027)
9.3 Latin America Non-GLP Acute Toxicology Market Size by Application
9.3.1 Latin America Non-GLP Acute Toxicology Market Size by Application (2016-2021)
9.3.2 Latin America Non-GLP Acute Toxicology Market Size by Application (2022-2027)
9.3.3 Latin America Non-GLP Acute Toxicology Market Size by Application (2016-2027)
9.4 Latin America Non-GLP Acute Toxicology Market Size by Country
9.4.1 Latin America Non-GLP Acute Toxicology Market Size by Country (2016-2021)
9.4.2 Latin America Non-GLP Acute Toxicology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-GLP Acute Toxicology Market Size (2016-2027)
10.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type
10.2.1 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application
10.3.1 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-GLP Acute Toxicology Market Size by Country
10.4.1 Middle East & Africa Non-GLP Acute Toxicology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 HSRL
11.1.1 HSRL Company Details
11.1.2 HSRL Business Overview
11.1.3 HSRL Non-GLP Acute Toxicology Introduction
11.1.4 HSRL Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.1.5 HSRL Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Non-GLP Acute Toxicology Introduction
11.2.4 Charles River Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.2.5 Charles River Recent Development
11.3 IITRI
11.3.1 IITRI Company Details
11.3.2 IITRI Business Overview
11.3.3 IITRI Non-GLP Acute Toxicology Introduction
11.3.4 IITRI Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.3.5 IITRI Recent Development
11.4 CARE Research
11.4.1 CARE Research Company Details
11.4.2 CARE Research Business Overview
11.4.3 CARE Research Non-GLP Acute Toxicology Introduction
11.4.4 CARE Research Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.4.5 CARE Research Recent Development
11.5 MediTox sro
11.5.1 MediTox sro Company Details
11.5.2 MediTox sro Business Overview
11.5.3 MediTox sro Non-GLP Acute Toxicology Introduction
11.5.4 MediTox sro Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.5.5 MediTox sro Recent Development
11.6 VivoPharm
11.6.1 VivoPharm Company Details
11.6.2 VivoPharm Business Overview
11.6.3 VivoPharm Non-GLP Acute Toxicology Introduction
11.6.4 VivoPharm Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.6.5 VivoPharm Recent Development
11.7 Celerion
11.7.1 Celerion Company Details
11.7.2 Celerion Business Overview
11.7.3 Celerion Non-GLP Acute Toxicology Introduction
11.7.4 Celerion Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.7.5 Celerion Recent Development
11.8 Bienta
11.8.1 Bienta Company Details
11.8.2 Bienta Business Overview
11.8.3 Bienta Non-GLP Acute Toxicology Introduction
11.8.4 Bienta Revenue in Non-GLP Acute Toxicology Business (2016-2021)
11.8.5 Bienta Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-GLP Acute Toxicology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acute Toxicity Testing
Table 3. Key Players of In vitro Cytotoxicity Testing
Table 4. Key Players of Genotoxicity Testing
Table 5. Global Non-GLP Acute Toxicology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non-GLP Acute Toxicology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Non-GLP Acute Toxicology Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Non-GLP Acute Toxicology Market Share by Regions (2016-2021)
Table 9. Global Non-GLP Acute Toxicology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Non-GLP Acute Toxicology Market Share by Regions (2022-2027)
Table 11. Non-GLP Acute Toxicology Market Trends
Table 12. Non-GLP Acute Toxicology Market Drivers
Table 13. Non-GLP Acute Toxicology Market Challenges
Table 14. Non-GLP Acute Toxicology Market Restraints
Table 15. Global Non-GLP Acute Toxicology Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Non-GLP Acute Toxicology Market Share by Players (2016-2021)
Table 17. Global Top Non-GLP Acute Toxicology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-GLP Acute Toxicology as of 2020)
Table 18. Ranking of Global Top Non-GLP Acute Toxicology Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Non-GLP Acute Toxicology Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Non-GLP Acute Toxicology Product Solution and Service
Table 22. Date of Enter into Non-GLP Acute Toxicology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Non-GLP Acute Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Non-GLP Acute Toxicology Revenue Market Share by Type (2016-2021)
Table 26. Global Non-GLP Acute Toxicology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Non-GLP Acute Toxicology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Non-GLP Acute Toxicology Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Non-GLP Acute Toxicology Revenue Market Share by Application (2016-2021)
Table 30. Global Non-GLP Acute Toxicology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Non-GLP Acute Toxicology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Non-GLP Acute Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Non-GLP Acute Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Non-GLP Acute Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Non-GLP Acute Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Non-GLP Acute Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Non-GLP Acute Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Non-GLP Acute Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Non-GLP Acute Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Non-GLP Acute Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Non-GLP Acute Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Non-GLP Acute Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Non-GLP Acute Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Non-GLP Acute Toxicology Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Non-GLP Acute Toxicology Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Non-GLP Acute Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Non-GLP Acute Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Non-GLP Acute Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Non-GLP Acute Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Non-GLP Acute Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Non-GLP Acute Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Non-GLP Acute Toxicology Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Non-GLP Acute Toxicology Market Size by Country (2022-2027) & (US$ Million)
Table 62. HSRL Company Details
Table 63. HSRL Business Overview
Table 64. HSRL Non-GLP Acute Toxicology Product
Table 65. HSRL Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 66. HSRL Recent Development
Table 67. Charles River Company Details
Table 68. Charles River Business Overview
Table 69. Charles River Non-GLP Acute Toxicology Product
Table 70. Charles River Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 71. Charles River Recent Development
Table 72. IITRI Company Details
Table 73. IITRI Business Overview
Table 74. IITRI Non-GLP Acute Toxicology Product
Table 75. IITRI Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 76. IITRI Recent Development
Table 77. CARE Research Company Details
Table 78. CARE Research Business Overview
Table 79. CARE Research Non-GLP Acute Toxicology Product
Table 80. CARE Research Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 81. CARE Research Recent Development
Table 82. MediTox sro Company Details
Table 83. MediTox sro Business Overview
Table 84. MediTox sro Non-GLP Acute Toxicology Product
Table 85. MediTox sro Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 86. MediTox sro Recent Development
Table 87. VivoPharm Company Details
Table 88. VivoPharm Business Overview
Table 89. VivoPharm Non-GLP Acute Toxicology Product
Table 90. VivoPharm Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 91. VivoPharm Recent Development
Table 92. Celerion Company Details
Table 93. Celerion Business Overview
Table 94. Celerion Non-GLP Acute Toxicology Product
Table 95. Celerion Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 96. Celerion Recent Development
Table 97. Bienta Company Details
Table 98. Bienta Business Overview
Table 99. Bienta Revenue in Non-GLP Acute Toxicology Business (2016-2021) & (US$ Million)
Table 100. Bienta Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-GLP Acute Toxicology Market Share by Type: 2020 VS 2027
Figure 2. Acute Toxicity Testing Features
Figure 3. In vitro Cytotoxicity Testing Features
Figure 4. Genotoxicity Testing Features
Figure 5. Global Non-GLP Acute Toxicology Market Share by Application: 2020 VS 2027
Figure 6. Rodents Case Studies
Figure 7. Canine Case Studies
Figure 8. Rabbit Case Studies
Figure 9. Others Case Studies
Figure 10. Non-GLP Acute Toxicology Report Years Considered
Figure 11. Global Non-GLP Acute Toxicology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Non-GLP Acute Toxicology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Non-GLP Acute Toxicology Market Share by Regions: 2020 VS 2027
Figure 14. Global Non-GLP Acute Toxicology Market Share by Regions (2022-2027)
Figure 15. Global Non-GLP Acute Toxicology Market Share by Players in 2020
Figure 16. Global Top Non-GLP Acute Toxicology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-GLP Acute Toxicology as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Non-GLP Acute Toxicology Revenue in 2020
Figure 18. Global Non-GLP Acute Toxicology Revenue Market Share by Type (2016-2021)
Figure 19. Global Non-GLP Acute Toxicology Revenue Market Share by Type (2022-2027)
Figure 20. North America Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Non-GLP Acute Toxicology Market Share by Type (2016-2027)
Figure 22. North America Non-GLP Acute Toxicology Market Share by Application (2016-2027)
Figure 23. North America Non-GLP Acute Toxicology Market Share by Country (2016-2027)
Figure 24. United States Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-GLP Acute Toxicology Market Share by Type (2016-2027)
Figure 28. Europe Non-GLP Acute Toxicology Market Share by Application (2016-2027)
Figure 29. Europe Non-GLP Acute Toxicology Market Share by Country (2016-2027)
Figure 30. Germany Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-GLP Acute Toxicology Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Non-GLP Acute Toxicology Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Non-GLP Acute Toxicology Market Share by Region (2016-2027)
Figure 40. China Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-GLP Acute Toxicology Market Share by Type (2016-2027)
Figure 48. Latin America Non-GLP Acute Toxicology Market Share by Application (2016-2027)
Figure 49. Latin America Non-GLP Acute Toxicology Market Share by Country (2016-2027)
Figure 50. Mexico Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-GLP Acute Toxicology Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Non-GLP Acute Toxicology Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Non-GLP Acute Toxicology Market Share by Country (2016-2027)
Figure 56. Turkey Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Non-GLP Acute Toxicology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. HSRL Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 60. Charles River Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 61. IITRI Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 62. CARE Research Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 63. MediTox sro Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 64. VivoPharm Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 65. Celerion Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 66. Bienta Revenue Growth Rate in Non-GLP Acute Toxicology Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---